Aehr Test (AEHR) Q3 2025 Earnings Call Transcript

Aehr Test reported Q3 revenue of $18.3M, up 142% YoY, driven by commercial shipments of FOX‑XP wafer‑level burn‑in systems for AI processors; bookings were $24.1M (vs. $9.2M prior quarter) with backlog $18.2M (effective backlog $21.8M after $3.6M subsequent bookings). Non‑GAAP gross margin held at 42.7% and non‑GAAP net income was $2.0M ($0.07/diluted) versus a prior‑year non‑GAAP loss; cash and investments were $31.4M with no debt. Management withdrew fiscal guidance due to U.S. tariff‑related timing uncertainty and flagged expected additional legal expenses; AI processors now represent >35% of business and InCal integration remains on track for completion by May 30.

Analysis

Aehr's technical edge on both wafer-level and package-level stress test creates an embedded, recurring-revenue vector that most public comparables can’t easily replicate — the long-term value is less about single-system sales and more about predictable consumable and service streams driven by qualified, installed systems in OSATs and hyperscalers. That implies a multiplier on installed-base cash generation: small unit volumes today can convert into steady high-margin annuity over 12–36 months as customers scale production and consume wafer-contactors and handling modules.

Tariff announcements are a volatility amplifier, not a demand destroyer, but the second‑order effect matters: customers that can swap logistics or delay acceptance will, creating lumpy near-term timing risk. Supply‑chain flexibility (buffered components and drop-ship options) is therefore a competitive barrier for short-cycle orders; conversely, suppliers tied to single‑origin probers or customs routes become execution chokepoints and optionality sinks.

The real binary risks live outside near-term bookings: an adverse IP outcome in China or an OSAT-level qualification failure would stall multi-year annuity conversion, while accelerated adoption of wafer-level screening across multiple large customers would compound revenue and margin expansion. Watch three horizons: days (tariff headlines that move order timing), months (qualification wins and OSAT installs that convert to repeat orders), and 12–24 months (consumable replacement cadence and flash/DRAM program commercialization) — each has distinct price and volume sensitivities.

Key Decisions for Investors

• Long AEHR (size 1–2% portfolio): add on any headline-driven pullback >15% within the next 30 trading days; target asymmetric upside over 12 months driven by installed-base annuity (2x potential) with a tactical stop-loss at -35% to limit execution/qualification risk.
• Buy AEHR 12–18 month call spread (risk‑defined): purchase a LEAP call ~25–50% OTM and sell a higher strike ~100–150% OTM to cap cost; use this if you want convex upside to a multi-customer wafer-level ramp while limiting premium at-risk to <3–5% of position size.
• Event hedge / protection: if holding AEHR into near-term tariff or legal headlines, buy 6–9 month puts (or collars) equal to ~25% notional of equity stake to protect against downside from order delays or an adverse IP ruling — treat as insurance premium against a concentrated binary.
• Tactical monitoring trade (watchlist): avoid one-way exposure in competing probe/prober suppliers that rely on single-country shipments; if a supplier-specific tariff report appears, consider shorting short-dated strength in that supplier or buying protection on that supplier to exploit execution risk, while keeping AEHR long exposure modest and time‑staggered.